Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines

Virus Research

Volumn 139, Issue 1, 2009, Pages 22-31

  Olivares, Isabel ^a   Ballester, Alicia ^a   Lombardia, Luis ^b   Dominguez, Orlando ^b   López Galíndez, Cecilio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

HIV 1; In vitro; Latency; Microarrays; Persistence

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS ISOLATION;

CELL LINE, TUMOR; CHRONIC DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; U937 CELLS; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 57749102540     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.09.010     Document Type: Article

References (48)

1. Ahmed R., Morrison L.A., and Knipe D.M. Persistence of viruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology. third ed. (1996), Lippicott-Raven Press, Philadelphia, PA 219-249
2. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57 (1995) 289-300
3. Blankson J.N., Persaud D., and Siliciano R.F. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53 (2002) 557-593
4. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., and Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 5865 (2008) 921-926
5. Cayirlioglu P., and Duronio R.J. Cell cycle: flies teach an old dogma new tricks. Curr. Biol. 11 5 (2001) R178-R181
6. Corbeil J., Sheeter D., Genini D., Rought S., Leoni L., Du P., Ferguson M., Masys D.R., Welsh J.B., Fink J.L., Sasik R., Huang D., Drenkow J., Richman D.D., and Gingeras T. Temporal gene regulation during HIV-1 infection of human CD4+ T cells. Genome Res. 11 7 (2001) 1198-1204
7. Chan E.Y., Qian W.J., Diamond D.L., Liu T., Gritsenko M.A., Monroe M.E., Camp II D.G., Smith R.D., and Katze M.G. Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J. Virol. 81 14 (2007) 7571-7583
8. Chen P., Hubner W., Spinelli M.A., and Chen B.K. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81 22 (2007) 12582-12595
9. Chowdhury I.H., Wang X.F., Landau N.R., Robb M.L., Polonis V.R., Birx D.L., and Kim J.H. HIV-1 Vpr activates cell cycle inhibitor p21/Wafl/Cipl: a potential mechanism of G2/M cell cycle arrest. Virology 305 2 (2003) 371-377
10. Chun T.W., and Fauci A.S. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl. Acad. Sci. U. S. A. 96 20 (1999) 10958-10961
11. de Mareuil J., Carre M., Barbier P., Campbell G.R., Lancelot S., Opi S., Esquieu D., Watkins J.D., Prevot C., Braguer D., Peyrot V., and Loret E.P. HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2 (2005) 5
12. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 5 (2003) P3
13. Emiliani S., Fischle W., Ott M., Van Lint C., Amelia C.A., and Verdin E. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol. 72 2 (1998) 1666-1670
14. Emiliani S., Van Lint C., Fischle W., Paras Jr. P., Ott M., Brady J., and Verdin E. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. U. S. A. 93 13 (1996) 6377-6381
15. Fernandez Larrosa P.N., Croci D.O., Riva D.A., Bibini M., Luzzi R., Saracco M., Mersich S.E., Rabinovich G.A., and Martinez Peralta L. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology 5 1 (2008) 19
16. Giri M.S., Nebozhyn M., Showe L., and Montaner L.J. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J. Leukoc. Biol. 80 5 (2006) 1031-1043
17. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 10 (2003) R70 Epub 2003 Sep 11
18. Jolly C., Mitar I., and Sattentau Q.J. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J. Virol. 81 11 (2007) 5547-5560
19. Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., and Chen I.S. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69 10 (1995) 6304-6313
20. Kamal A.M., Flower R.J., and Perretti M. An overview of the effects of annexin 1 on cells involved in the inflammatory process. Mem. Inst. Oswaldo Cruz. 100 Suppl. 1 (2005) 39-47
21. Krishnan V., and Zeichner S.L. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J. Virol. 78 17 (2004) 9458-9473
22. Lei M., and Tye B.K. Initiating DNA synthesis: from recruiting to activating the MCM complex. J. Cell Sci. 114 Pt 8 (2001) 1447-1454
23. Lennon G., Auffray C., Polymeropoulos M., and Soares M.B. The I. M. A. G. E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 33 1 (1996) 151-152
24. Lue H., Thiele M., Franz J., Dahl E., Speckgens S., Leng L., Fingerle-Rowson G., Bucala R., Luscher B., and Bernhagen J. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26 35 (2007) 5046-5059
25. Martinez-Delgado B., Melendez B., Cuadros M., Alvarez J., Castrillo J.M., Ruiz De La Parte A., Mollejo M., Bellas C., Diaz R., Lombardia L., Al-Shahrour F., Dominguez O., Cascon A., Robledo M., Rivas C., and Benitez J. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin. Cancer Res. 10 15 (2004) 4971-4982
26. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 33 5 (2000) 261-274
27. Munier S., Delcroix-Genete D., Carthagena L., Gumez A., and Hazan U. Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency. Retrovirology 2 (2005) 73
28. Olivares I., Casado Herrero C., Iglesias-Ussel M.D., Dietrich U., and Lopez Galindez C. Complete sequence of an infectious molecular clone derived from a Spanish HIV type I isolate. AIDS Res. Hum. Retroviruses 14 18 (1998) 1649-1651
29. Olivares I., Shaw G., and Lopez-Galindez C. Phenotypic switch in a Spanish HIV type 1 isolate on serial passage on MT-4 cells. AIDS Res. Hum. Retroviruses 13 11 (1997) 979-984
30. Pantaleo G., and Fauci A.S. Apoptosis in HIV infection. Nat. Med. 1 2 (1995) 118-120
31. Re F., Braaten D., Franke E.K., and Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69 11 (1995) 6859-6864
32. Ruetz S., Fabbro D., Zimmermann J., Meyer T., and Gray N. Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors. Curr. Med. Chem. Anticancer Agents 3 1 (2003) 1-14
33. Sanchez-Merino V., Munoz L., Perez-Pastrana M.E., Herrera M.I., Olivares I., and Lopez-Galindez C. Genetic changes associated with distinct patterns of HIV type 1 persistence in chronically infected cell lines. AIDS Res. Hum. Retroviruses 23 2 (2007) 251-260
34. Sanchez-Palomino S., Rojas J.M., Martinez M.A., Fenyo E.M., Najera R., Domingo E., and Lopez-Galindez C. Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. J. Virol. 67 5 (1993) 2938-2943
35. Sandstrom E.G., Schooley R.T., Ho D.D., Byington R., Sarngadharan M.G., MacLane M.E., Essex M., Gallo R.C., and Hirsch M.S. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion 25 4 (1985) 308-312
36. Sanjo H., Kawai T., and Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J. Biol. Chem. 273 44 (1998) 29066-29071
37. Schlaepfer E., Audige A., Joller H., and Speck R.F. TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J. Immunol. 176 5 (2006) 2888-2895
38. Smyth G.K., and Speed T. Normalization of cDNA microarray data. Methods 31 4 (2003) 265-273
39. Thomson B.J. Viruses and apoptosis. Int. J. Exp. Pathol. 82 2 (2001) 65-76
40. Tracey L., Spiteri I., Ortiz P., Lawler M., Piris M.A., and Villuendas R. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. J. Interferon Cytokine Res. 24 3 (2004) 185-195
41. Tracey L., Villuendas R., Dotor A.M., Spiteri I., Ortiz P., Garcia J.F., Peralto J.L., Lawler M., and Piris M.A. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 102 3 (2003) 1042-1050
42. Tracey L., Villuendas R., Ortiz P., Dopazo A., Spiteri I., Lombardia L., Rodriguez-Peralto J.L., Fernandez-Herrera J., Hernandez A., Fraga J., Dominguez O., Herrero J., Alonso M.A., Dopazo J., and Piris M.A. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am. J. Pathol. 161 5 (2002) 1825-1837
43. van't Wout A.B., Lehrman G.K., Mikheeva S.A., O'Keeffe G.C., Katze M.G., Bumgarner R.E., Geiss G.K., and Mullins J.I. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J. Virol. 77 2 (2003) 1392-1402
44. Van Lint C., Emiliani S., Ott M., and Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15 5 (1996) 1112-1120
45. Vazquez N., Greenwell-Wild T., Marinos N.J., Swaim W.D., Nares S., Ott D.E., Schubert U., Henklein P., Orenstein J.M., Sporn M.B., and Wahl S.M. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79 7 (2005) 4479-4491
46. Vicente-Manzanares M., and Sanchez-Madrid F. Role of the cytoskeleton during leukocyte responses. Nat. Rev. Immunol. 4 2 (2004) 110-122
47. Wahl S.M., Greenwell-Wild T., Peng G., Ma G., Orenstein J.M., and Vazquez N. Viral and host cofactors facilitate HIV-1 replication in macrophages. J. Leukoc. Biol. 74 5 (2003) 726-735
48. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., and Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30 4 (2002) e15